Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Update

Avalon GloboCare Corp. (NASDAQ:ALBT) was the recipient of a significant growth in short interest in December. As of December 15th, there was short interest totalling 114,200 shares, a growth of 275.7% from the November 30th total of 30,400 shares. Based on an average daily trading volume, of 1,420,000 shares, the days-to-cover ratio is presently 0.1 days. Currently, 27.0% of the company’s stock are sold short.

Avalon GloboCare Stock Down 7.1 %

NASDAQ:ALBT traded down $0.29 during trading hours on Thursday, reaching $3.81. 18,138 shares of the stock were exchanged, compared to its average volume of 498,755. The stock has a market capitalization of $4.17 million, a P/E ratio of -0.19 and a beta of 0.27. The firm has a 50 day simple moving average of $3.24 and a 200-day simple moving average of $4.45. Avalon GloboCare has a 52 week low of $2.11 and a 52 week high of $21.60.

About Avalon GloboCare

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.